EQ Health Acquisition Corp. Announces that Class A Common Stock and Warrants to Commence Separate Trading on or about March 22, 2021

Rhea-AI Summary

EQ Health Acquisition Corp. (NYSE:EQHA.U) announced that holders of its units can trade Class A common stock and warrants separately starting March 22, 2021. The Class A common stock will be traded under the symbol EQHA, while the warrants will be under EQHA WS. Only whole warrants will be traded, and units not separated will still trade under EQHA.U. Investors must instruct their brokers to separate the units through Continental Stock Transfer & Trust Company. This follows a registration statement declared effective by the SEC on January 28, 2021.

Positive

• Holders can separate and trade the Class A common stock and warrants, enhancing liquidity.
• The registration statement was declared effective by the SEC, facilitating the trading transition.

Negative

• None.

EQ Health Acquisition Corp. (the “Company”) (NYSE:EQHA.U) today announced that holders of the Company’s units may elect to separately trade the Class A common stock and warrants included in its units commencing on or about March 22, 2021.

The Class A common stock and warrants will trade on the New York Stock Exchange (the “NYSE”) under the symbols EQHA and EQHA WS, respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Units not separated will continue to trade on the NYSE under the symbol EQHA.U.

Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company’s transfer agent, in order to separate the units into Class A common stock and warrants.

A registration statement relating to the units and the underlying securities was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on January 28, 2021.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. A copy of the final prospectus relating to the initial public offering may be obtained for free by visiting the SEC website at http://www.sec.gov. Alternatively, a copy of the prospectus related to the initial public offering may be obtained from Jefferies LLC, Attn: Equity Syndicate Prospectus Department, 520 Madison Avenue, 2nd Floor, New York, NY 10002, by telephone: 877-821-7388 or by email: Prospectus_Department@Jefferies.com; or BTIG, LLC, 65 East 55th Street, New York, NY 10022, email: equitycapitalmarkets@btig.com.

About the Company

Led by an operationally-focused management team with more than 50 years of collective experience in growth and value creation across multi-disciplined healthcare settings, EQ Health seeks healthcare services partners that are conventionally viewed as under-valued, but with opportunities for significant growth with enterprise values generally between $600 million and $1.25 billion. The Company targets the following focus areas within healthcare services: alternative-site providers and services, home care and hospice, payor services, behavioral health, dental, physical therapy and veterinary services.

Forward Looking Statements

This press release includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act") that are not historical facts, and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this press release, including, without limitation, regarding the Company’s business strategy, are forward-looking statements. Words such as “expect” and “intend” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the risk factors section of the Company’s final prospectus for its initial public offering and its subsequent filings with the SEC. The Company’s securities filings can be accessed on the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210318005239/en/

FAQ

When can holders trade Class A common stock and warrants of EQ Health Acquisition Corp.?

Holders can trade Class A common stock and warrants separately starting on March 22, 2021.

What are the trading symbols for Class A common stock and warrants for EQHA.U?

The Class A common stock trades under the symbol EQHA, and the warrants trade under EQHA WS.

What do holders need to do to separate their units into stock and warrants?

Holders must have their brokers contact Continental Stock Transfer & Trust Company to separate the units.

What is the status of the registration statement for EQ Health Acquisition Corp.?

The registration statement was declared effective by the SEC on January 28, 2021.